Display Title IMS June 2018 Weight 0 Tags IMS June 2018 Content Symptomatic Vulvar and Vaginal Atrophy (VVA) Relief was Achieved with Negligible to Very Low Systemic Absorption of Estradiol with TX-004HR (Estradiol Vaginal Insert): PK Comparison to Systemic and a Vaginal Estradiol 335.7 KB TX-004HR Provided Robust Improvement of Symptomatic Postmenopausal Vulvar and Vaginal Atrophy (VVA) with Negligible to Very Low Systemic Absorption of Estradiol: Results of Phase 1 and 3 Clinical Trials 462.3 KB Ultra-low Doses of TX-004HR (Estradiol Vaginal Insert) Improved Symptoms of Vulvar and Vaginal Atrophy while Maintaining Serum Levels of Estradiol within the Normal Postmenopausal Range 315.7 KB Ultra-low Doses of TX-004HR (Estradiol Vaginal Softgel Capsule) Improve Symptoms of Vulvar and Vaginal Atrophy while Maintaining Serum Levels of Estradiol within the Normal Postmenopausal Range 80.5 KB TX-004HR Provides Robust Improvement of Symptomatic Postmenopausal Vulvar and Vaginal Atrophy (VVA) with Negligible Systemic Absorption of Estradiol: Results of Phase 1 and 3 Clinical Trials 87.8 KB Symptomatic Vulvar and Vaginal Atrophy (VVA) Relief was Achieved with Negligible to Very Low Systemic Absorption of Estradiol with TX-004HR (Estradiol Vaginal Insert): PK Comparison to Systemic and a Vaginal Estradiol 335.7 KB Categories Publications
